Insights on Clinical Trials

  1. Quantitative ROI With DCTs 11/13/2025

    Through dedicated staffing, operational oversight, and collaboration with site teams, see how we were able to transform a struggling cardiology study into a revitalized recruitment effort.

  2. The True ROI Of Decentralized Clinical Trials 11/13/2025

    Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.

  3. How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology? 11/7/2025

    By directing radioactive isotopes straight to diseased tissue, these agents deliver potent, localized treatment while sparing healthy cells — a major leap forward for patients with metastatic or treatment-resistant cancers.

  4. Addressing A Global Health Priority In Australia And New Zealand 11/7/2025

    For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.

  5. Highlights From The 2025 International Hepatitis B Meeting 11/7/2025

    For biotech and pharmaceutical teams, the core message was clear: progress is accelerating, but success still depends on smart study design, fit-for-purpose endpoints, and operational execution.

  6. How CROs, Sites, PIs, And Sponsors Work Better Together 11/7/2025

    Each role is critical, yet operating in isolation results in slower timelines, duplicated effort, and missed opportunities. When collaboration replaces coordination, trials gain speed, quality, and patient trust.

  7. Therapeutic Radiopharmaceuticals: Clinical Research, CRO Enablers (2025) 11/7/2025

    Accelerate the future of precision oncology by driving innovation, optimizing clinical development, and expanding access to targeted therapies that transform patient outcomes.

  8. How Emerging Technologies Are Challenging Traditional IRB Oversight 11/6/2025

    Uncover how sponsors, CROs, and study monitors can navigate FDA expectations and Institutional Review Board (IRB) requirements when integrating AI and Software-as-a-Medical-Device into clinical trials.

  9. Global Implications Of Zero Tariffs On Indian Pharma Exports To China 11/5/2025

    Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.

  10. Tips For Partnering With Health Systems: A Critical Step For CGT Commercialization 11/3/2025

    Collaborating with health systems is key to CGT commercialization. Learn how to address operational and financial challenges to ensure processes are scalable and patient access is streamlined.